Wellin participated in an independent, randomized double-blind placebo-controlled clinical trial on healthy, non-osteoarthritic individuals. in 2018. Male and female middle-aged subjects were given 4g of Keriflex™ or placebo daily for 8 weeks to determine the effects on joint discomfort, joint stiffness and the physical function of the knee and overall health of the neck and lower back.
Keriflex™ has been clinically shown to improve overall joint health. Personal ailments were assessed using the Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC).
Clinical trial participants experienced a "37% improvement in their physical function."
Additional physical improvements reported by participants include increased mobility when removing socks (58%), getting in and out of a bathtub (55%), and descending stairs (32%).
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat or cure any disease. Anyone suffering from any illness, injury or disease should consult with a physician.